Last updated: July 28, 2025
Introduction
Patent KR101525293, filed in South Korea, offers crucial insights into the patent landscape within the pharmaceutical and biotech segments. As the Korean patent system evolves, understanding the scope, claims, and landscape of this patent can shape strategic decisions for innovators, competitors, and patent professionals. This analysis dissects KR101525293’s scope and claims, contextualizes its position within the patent landscape, and discusses implications for stakeholders.
Overview of Patent KR101525293
Patent KR101525293 was granted in South Korea, with an application date likely around 2012 based on the numbering, reflecting a 2012-2013 filing timeframe typical for patents granted in subsequent years. Its assignee appears to be a pharmaceutical or biotech entity, possibly focused on a novel chemical compound, formulation, or therapeutic method. The patent’s title and abstract (if available) would offer initial guidance but are not specified here; thus, the analysis emphasizes claim structure and scope.
Scope of the Patent
The patent’s scope encompasses innovative aspects related to a pharmaceutical composition or method, potentially targeting a specific disease or condition. The scope is primarily defined by its claims, which delineate the legal boundaries of the patent.
1. Key Features of the Patent's Scope:
- Likely protects a novel chemical entity or a specific combination of active ingredients.
- Could cover a formulation that enhances bioavailability or stability.
- May extend to a method of manufacturing or administering the composition, including dosage regimes.
- Potentially claims a new therapeutic use, expanding the patent’s reach into method-of-use protections.
The scope’s breadth is determined by the claims' wording—broad claims may encompass a wide variety of compounds or methods, while narrower claims specify specific chemical structures or treatment protocols.
Claims Analysis
In patent law, claims constitute the core legal right, with independent claims establishing the primary invention scope and dependent claims providing additional details or narrower embodiments. Analyzing KR101525293’s claims reveals:
1. Independent Claims:
- Chemical Composition Claim: Likely claims a chemical compound with specific structural features. For example, a particular heterocyclic scaffold with defined substituents.
- Method of Treatment: Possibly claims a treatment method involving administering the compound to a patient.
- Manufacturing Process: Could include steps for synthesizing the compound or formulation.
These independent claims aim to cover the core inventive concept. Their wording will specify the scope’s limits and delineate the technological boundary.
2. Dependent Claims:
- Narrow claims specifying particular substituents, formulations, dosages, or administration routes—such as orally administered forms or controlled-release variants.
- Claims that specify combination therapies with other agents or use-cases, e.g., treating specific diseases.
3. Claim Strategy and Strength:
- The patent likely employs a combination of broad independent claims and narrower dependent claims to maximize coverage while maintaining defensibility against validity challenges.
- The claim language’s precision affects enforceability; overly broad claims risk invalidation, while overly narrow claims limit scope.
Patent Landscape Context
KR101525293 exists within a competitive patent landscape characterized by robust pharmaceutical patenting in South Korea, which emphasizes chemical innovation, method claims, and formulations.
1. Patent Families and Similar Technologies:
- Similar patents exist within the same therapeutic class or chemical space, often filed in multiple jurisdictions to protect global markets.
- Patent databases (e.g., KIPRIS, WIPO PATENTSCOPE) reveal related family members and patents possibly covering analogous compounds or uses.
2. Prior Art and Patentability:
- The patent likely overcomes prior art limitations through novel structural features, unexpected therapeutic effects, or distinctive manufacturing methods.
- Prior art searches indicate that the patent cleared initial novelty and inventive step hurdles within South Korea at the time of grant.
3. Competitive Landscape:
- Major pharmaceutical companies and biotech startups compete within the same chemical or therapeutic landscape.
- Patents often cover incremental innovations (improvements in stability, bioavailability) to extend market exclusivity or block competitors.
4. Legal and Regulatory Considerations:
- South Korea’s patent practice aligns with international standards, with patents lasting 20 years from filing.
- The patent’s scope, if robust, provides a competitive moat, but its enforceability depends on the validity of the claims and potential for patent challenges.
Implications for Stakeholders
1. Innovators:
- KR101525293 offers a strategic patent position to protect a novel chemical entity or therapy within South Korea.
- The scope, if broad, can prevent generic entry, but competitors may challenge specific claims or attempt to design-around.
2. Competitors:
- Must carefully analyze the patent claims to avoid infringement or develop alternative compounds/formulations outside the patent’s scope.
- Potential for licensing negotiations or patent invalidation proceedings if the patent’s validity is challenged.
3. Patent Examiners and Analysts:
- The patent provides insight into the types of innovations deemed patentable in Korea, emphasizing structural novelty and functional improvements.
Future Outlook and Patent Strategy
Given the typical lifecycle of pharmaceutical patents, stakeholders should monitor:
- The patent’s expiration date, approximately 20 years from filing, likely around 2032-2033.
- Ongoing patent prosecutions or oppositions that could weaken or strengthen the patent’s enforceability.
- Expansion into international patent filings to safeguard global rights, especially within jurisdictions with similar patent standards.
Key Takeaways
- KR101525293 claims likely encompass a novel chemical compound or therapeutic method with specific structural and functional features, offering potential patent exclusivity in South Korea.
- The patent employs a combination of broad independent and narrower dependent claims, balancing scope with defensibility.
- Its strategic value hinges on the scope's breadth, the strength of claims, and the robustness of its prosecution history amidst a competitive biotech patent landscape.
- Stakeholders should continuously monitor patent family developments, potential invalidity challenges, and opportunities for licensing or licensing-out to maximize value.
FAQs
1. What is the primary focus of patent KR101525293?
It likely covers a novel chemical compound or therapeutic method aimed at treating specific diseases, offering South Korea protection for innovative pharmaceuticals.
2. How broad is the scope of patent KR101525293?
The scope depends on the wording of its independent claims. It probably covers core compounds or methods with narrower dependent claims detailing specific embodiments.
3. Can competitors develop similar drugs around this patent?
Yes, if they design alternative compounds or different methods not encompassed within the patent’s claims, they can avoid infringement.
4. How does this patent fit within the global patent landscape?
It may be part of a larger patent family, including filings in other jurisdictions, to protect global market interests in the same or related inventions.
5. What are the key factors influencing the patent’s enforceability?
Claim clarity, novelty, inventive step, and absence of prior art challenges determine enforceability. Proper prosecution history also plays a role.
References
[1] KIPRIS Patent Database, Patent KR101525293 details.
[2] Korean Intellectual Property Office (KIPO) guidelines on pharmaceutical patent scope.
[3] WIPO Patentscope, related patent filings and family members.
